Recombinant human erythropoietin 2 (STAR-2)

epoetin alfa · Janssen-Cilag B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Recombinant human erythropoietin 2 (STAR-2), covering 2012-11-06 to 2012-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Survey on the Treatment of Anemia Using Recombinant Human Erythropoietin 2 (STAR-2)